← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-146 | 70713-146-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:776 | 776 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:776 | 776 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyoscyamine Sulfate; Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:776 | 776 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-50 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1114 | 73271-1114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6013 | 26436-6013-1 | Lidocaine Hydrochloride Anhydrous; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:776 | 776 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2369 | 72934-2369-2 | Ketoconazole; Hydrocortisone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-589 | 69194-589-01 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-5 | Methylprednisolone Acetate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:776 | 776 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:777 | 777 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone 30mg per 30mL Syringe | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-052 | 70713-052-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:777 | 777 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:777 | 777 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ibutamoren Mesylate | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-246 | 70731-246-55 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3114 | 73271-3114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:777 | 777 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:777 | 777 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2370 | 72934-2370-2 | Ketoconazole; Hydrocortisone; Iodoquinol | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:777 | 777 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Chloride; Zinc Sulfate Heptahydrate; Copper Gluconate; Manganese Sulfate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-916 | 69852-916-10 | Methylprednisolone Acetate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:777 | 777 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4604 | 72934-4604-8 | Minoxidil; Betamethasone Dipropionate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:778 | 778 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1036 | 73013-1036-1 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-983 | 69374-983-30 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:778 | 778 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Idoxuridine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9021 | 26436-9021-4 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:778 | 778 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:778 | 778 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-7114 | 73271-7114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-586 | 70092-586-43 | Lidocaine Hydrochloride; Epinephrine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:778 | 778 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2363 | 72934-2363-2 | Ketoconazole; Niacinamide | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:778 | 778 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Magnesium Sulfate Heptahydrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:778 | 778 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-115 | 69852-115-10 | Methylprednisolone Acetate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:778 | 778 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4610 | 72934-4610-8 | Minoxidil; Niacinamide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:779 | 779 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-384 | 73693-384-01 | TESTOSTERONE 100 MG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-013 | 70713-013-01 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-983 | 69374-983-01 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2418 | 72627-2418-1 | Inositol; Choline Chloride; Methionine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9020 | 26436-9020-2 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:779 | 779 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:779 | 779 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4114 | 73271-4114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:779 | 779 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6442 | 71300-6442-2 | Ketoprofen | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:779 | 779 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-2 | Midazolam | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:779 | 779 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4609 | 72934-4609-8 | Minoxidil; Progesterone | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:780 | 780 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | HYDROMORPHONE 50MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2010 | 70168-2010-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-983 | 69374-983-50 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2419 | 72627-2419-1 | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-065 | 70713-065-09 | Hydroxychloroquine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:780 | 780 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2114 | 73271-2114-1 | Lidocaine; Prilocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0037 | 81483-0037-0 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-043 | 71506-043-01 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-161 | 73177-161-43 | Methadone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5030 | 71266-5030-1 | Midazolam | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:780 | 780 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4602 | 72934-4602-8 | Minoxidil; Tretinoin; Fluocinolone Acetonide | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:781 | 781 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-159 | 73177-159-02 | Rocuronium Bromide | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2020 | 70168-2020-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-50 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2420 | 72627-2420-1 | Inositol; Choline Chloride; Methionine; Levocarnitine; Thiamine Hydrochloride; Dexpanthenol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-064 | 70713-064-09 | Hydroxychloroquine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:781 | 781 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:781 | 781 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9091 | 71266-9091-1 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-527 | 65302-527-15 | Ketorolac Tromethamine; Bupivacaine Hydrochloride; Ketamine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:781 | 781 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-43 | Methadone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:781 | 781 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-3 | Mitomycin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:782 | 782 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-376 | 73693-376-01 | ESTRADIOL 20MG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0010 | 71138-0010-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-529 | 69374-529-30 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0754 | 5446-0754-01 | Iodine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-9200 | 79559-9200-1 | Hydroxychloroquine Sulfate | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:782 | 782 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:782 | 782 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:782 | 782 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketorolac Tromethamine; Phenylephrine Hydrochloride; Tropicamide | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:782 | 782 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0205 | 72196-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-01 | Midazolam | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:782 | 782 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-3 | Mitomycin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:783 | 783 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6075 | 72196-6075-1 | Vancomycin 1.5gm added to D5W | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:783 | 783 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0125 | 71138-0125-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:783 | 783 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3135 | 62295-3135-5 | Iohexol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Idoxuridine | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:783 | 783 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-066 | 71506-066-10 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:783 | 783 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-433 | 70092-433-50 | Ketorolac Tromethamine; Racepinephrine Hydrochloride; Clonidine Hydrochloride; Ropivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:783 | 783 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:783 | 783 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:783 | 783 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:783 | 783 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-103 | 81375-103-40 | Mitomycin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:784 | 784 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1032 | 73013-1032-1 | Hydromorphone HCl | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:784 | 784 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0020 | 71138-0020-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:784 | 784 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6477 | 71266-6477-5 | Iohexol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:784 | 784 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2418 | 72627-2418-1 | Inositol; Choline Chloride; Methionine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:784 | 784 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:784 | 784 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-161 | 73177-161-43 | Methadone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:784 | 784 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:784 | 784 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:784 | 784 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-100 | 81375-100-40 | Mitomycin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:785 | 785 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-13 | Oxycodone Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0022 | 71138-0022-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-1 | Hydromorphone Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6478 | 71266-6478-3 | Iohexol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2419 | 72627-2419-1 | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:785 | 785 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:785 | 785 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:785 | 785 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:785 | 785 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:785 | 785 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-503 | 65302-503-04 | Labetalol Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:785 | 785 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6420 | 72682-6420-1 | Methionine; Inositol; Choline Chloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:785 | 785 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8515 | 71266-8515-3 | Mitomycin | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:786 | 786 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1081 | 73013-1081-1 | Fentanyl Citrate (200mcg)- Bupivacaine HCl (0.1%) | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:786 | 786 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0015 | 71138-0015-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:786 | 786 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1326 | 61141-1326-1 | Iopamidol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:786 | 786 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2420 | 72627-2420-1 | Inositol; Choline Chloride; Methionine; Levocarnitine; Thiamine Hydrochloride; Dexpanthenol | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:786 | 786 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-090 | 71449-090-42 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:786 | 786 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-149 | 73177-149-43 | Methadone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:786 | 786 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5595 | 26436-5595-3 | Methionine; Inositol; Choline Chloride | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:786 | 786 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:787 | 787 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-002 | 70713-002-01 | TESTOSTERONE SA2 100MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:787 | 787 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0006 | 71138-0006-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ipamorelin; Growth Hormone-Releasing Hormone Receptor | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Insulin Human | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:787 | 787 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5594 | 26436-5594-3 | Methionine; Inositol; Choline Chloride; Cyanocobalamin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:787 | 787 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:787 | 787 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:788 | 788 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1028 | 73013-1028-1 | Fentanyl Citrate- Bupivacaine HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0018 | 71138-0018-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:788 | 788 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0413 | 71285-0413-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0754 | 5446-0754-01 | Iodine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:788 | 788 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:788 | 788 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:788 | 788 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-147 | 70092-147-03 | Lidocaine Hydrochloride; Potassium Chloride | 2022-2 | valid | 0 | 2026-10-17 |